v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total RadNet, Inc.'s Equity
Common Stock
Common Stock
Equity Incentive Plan
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     74,036,993          
Beginning balance at Dec. 31, 2024 $ 1,133,410 $ 902,308 $ 7   $ 988,147 $ (9,061) $ (76,785) $ 231,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of options (in shares)     114,814          
Issuance of common stock upon exercise of options 2,259 2,259 $ 1   2,258      
Issuance of common stock under the equity compensation plan (in shares)       1,039,311        
Stock-based compensation expense 46,466 46,466     46,466      
Forfeiture of restricted stock and share cancellation (in shares)     (7,116)          
Forfeiture of restricted stock and share cancellation (190) (190)     (190)      
Distributions paid to noncontrolling interests (3,313)             (3,313)
Contribution from noncontrolling partner 2,389             2,389
Issuance of common stock in connection with acquisitions (in shares)     1,848,152          
Issuance of common stock in connection with acquisitions 110,721 110,721     110,721      
Change in cumulative foreign currency translation adjustment 12,758 12,758       12,758    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 2,273 2,273       2,273    
Net (loss) income 7,186 (18,055)         (18,055) 25,241
Ending balance (in shares) at Sep. 30, 2025     77,032,154          
Ending balance at Sep. 30, 2025 1,313,959 1,058,540 $ 8   1,147,402 5,970 (94,840) 255,419
Beginning balance (in shares) at Jun. 30, 2025     75,067,102          
Beginning balance at Jun. 30, 2025 1,179,261 932,314 $ 8   1,025,936 6,627 (100,257) 246,947
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of options (in shares)     49,080          
Issuance of common stock upon exercise of options 1,704 1,704     1,704      
Issuance of common stock under the equity compensation plan (in shares)       68,599        
Stock-based compensation expense 9,191 9,191     9,191      
Forfeiture of restricted stock and share cancellation (in shares)     (779)          
Forfeiture of restricted stock and share cancellation (150) (150)     (150)      
Issuance of common stock in connection with acquisitions (in shares)     1,848,152          
Issuance of common stock in connection with acquisitions 110,721 110,721     110,721      
Change in cumulative foreign currency translation adjustment (874) (874)       (874)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 217 217       217    
Net (loss) income 13,889 5,417         5,417 8,472
Ending balance (in shares) at Sep. 30, 2025     77,032,154          
Ending balance at Sep. 30, 2025 $ 1,313,959 1,058,540 $ 8   1,147,402 5,970 (94,840) 255,419
Beginning balance (in shares) at Dec. 31, 2025 77,399,615   77,399,615          
Beginning balance at Dec. 31, 2025 $ 1,355,886 1,089,890 $ 8   1,180,434 4,885 (95,437) 265,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of options (in shares)     163,557          
Issuance of common stock upon exercise of options 2,517 2,517     2,517      
Issuance of common stock under the equity compensation plan (in shares)       1,001,868        
Stock-based compensation expense 52,106 52,106     52,106      
Forfeiture of restricted stock and share cancellation (in shares)     (21,233)          
Forfeiture of restricted stock and share cancellation (173) (173)     (173)      
Distributions paid to noncontrolling interests (8,362)             (8,362)
Sale of economic interests in majority owned subsidiary, net of taxes 8,848 8,848     8,848      
Issuance of common stock in connection with acquisitions (in shares)     224,993          
Issuance of common stock in connection with acquisitions 2,587 2,587     2,587      
Change in cumulative foreign currency translation adjustment (12,843) (12,696)       (12,696)   (147)
Noncontrolling interest recognized in business combination 21,640             21,640
Net (loss) income $ 14,673 (21,783)         (21,783) 36,456
Ending balance (in shares) at Sep. 30, 2026 78,768,800   78,768,800          
Ending balance at Sep. 30, 2026 $ 1,436,879 1,121,296 $ 8   1,246,319 (7,811) (117,220) 315,583
Beginning balance (in shares) at Jun. 30, 2026     78,646,805          
Beginning balance at Jun. 30, 2026 1,394,051 1,096,092 $ 8   1,222,961 (5,504) (121,373) 297,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of options (in shares)     67,885          
Issuance of common stock upon exercise of options 1,905 1,905     1,905      
Issuance of common stock under the equity compensation plan (in shares)       22,417        
Stock-based compensation expense 10,108 10,108     10,108      
Forfeiture of restricted stock and share cancellation (in shares)     (2,376)          
Forfeiture of restricted stock and share cancellation (90) (90)     (90)      
Distributions paid to noncontrolling interests (4,435)             (4,435)
Sale of economic interests in majority owned subsidiary, net of taxes 8,848 8,848     8,848      
Issuance of common stock in connection with acquisitions (in shares)     34,069          
Issuance of common stock in connection with acquisitions 2,587 2,587     2,587      
Change in cumulative foreign currency translation adjustment (2,293) (2,307)       (2,307)   14
Noncontrolling interest recognized in business combination 7,047             7,047
Net (loss) income $ 19,151 4,153         4,153 14,998
Ending balance (in shares) at Sep. 30, 2026 78,768,800   78,768,800          
Ending balance at Sep. 30, 2026 $ 1,436,879 $ 1,121,296 $ 8   $ 1,246,319 $ (7,811) $ (117,220) $ 315,583